Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
There is no head-to-head trial, so better cannot be established from evidence
Healthcare professionals should refer to MHRA guidance on the supply of unlicensed medicinal products ('specials') and GMC prescribing guidance for further detail
Anemia is another possible outcome
This enzymatic action depletes the available intracellular pool of nicotinamide, directly limiting the synthesis of nicotinamide adenine dinucleotide (NAD+)
bioRxiv, 2021;2021.2006.2013.448232, doi: Hemann, M
US$ 28.42
US$ 23.70
US$ 23.95
US$ 29.07
US$ 24.46
